H. Schmidt

Upregulated synthesis of both apolipoprotein A-I and apolipoprotein B in familial hyperalphalipoproteinemia and hyperbetalipoproteinemia.

M. Manns, R. Gregg, H. Brewer, 1998, Metabolism: clinical and experimental.

Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia.

E. Makariou, H. H. Schmidt, K. Dugi, 1996, The American journal of cardiology.

Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.

H. Brewer, R. Shamburek, H. H. Schmidt, 1998, The Journal of clinical endocrinology and metabolism.

Familial Amyloidotic Polyneuropathy: domino liver transplantation.

M. Manns, S. Kubicka, M. Nakazato, 1999, Journal of hepatology.

Erdheim-Chester disease: low low-density lipoprotein levels due to rapid catabolism.

B. Brewer, R. Gregg, R. Shamburek, 1997, Metabolism: clinical and experimental.

p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease

A. Członkowska, M. Rodo, H. H. Schmidt, 2006, Movement disorders : official journal of the Movement Disorder Society.

In vivo kinetics as a sensitive method for testing physiologically intact human recombinant apolipoprotein A-I: comparison of three different expression systems.

M. Manns, C. Strassburg, A. Remaley, 1997, Clinica chimica acta; international journal of clinical chemistry.

Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease

A. Członkowska, T. Litwin, G. Gromadzka, 2005, Clinical genetics.

Introducing single-nucleotide polymorphism markers in the diagnosis of Wilson disease.

H. Schmidt, 2007, Clinical chemistry.